Published: September 08, 2020
A spokesman for AstraZeneca, the company working on the coronavirus vaccine, said pausing trials was common during vaccine development
The development of a promising Covid-19 vaccine has been put on hold due to an adverse reaction in a trial participant.
A spokesman for AstraZeneca, the company working with a team from Oxford University, told the Guardian the trial has been stopped to review the “potentially unexplained illness” in one of the participants.
Continue reading...from The Guardian https://ift.tt/2ZhrneA
via
0 Comments